Argita Dyah Salindri

Argita Dyah Salindri

Auto-generated profile, based on publicly available information

Argita Dyah Salindri

Department of Population Health Sciences, Georgia State University School of Public Health, Hubert Department of Global Health, Emory University Rollins School of Public Health , Atlanta, Georgia

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 April 2018 in American Journal of Epidemiology
Verified
Journal Article
Open access
PDF file
GAGenet A Amere
Genet A Amere
PNPratibha Nayak
Pratibha Nayak
ASArgita D Salindri
Argita D Salindri
KNK M V Narayan
K M V Narayan
MMMatthew J Magee
Matthew J Magee
Globally, 10 million incident cases of tuberculosis (TB) are reported annually, and 95% of TB cases and 80% of tobacco users reside in low- and middle-income countries. Smoking approximately doubles the risk of TB disease and TB mortality. We estimated the proportion of annual incident TB cases and TB mortality attributable to tobacco smoking in 32 high-TB-burden countries. We obtained country-specific estimates of TB incidence, TB mortality, and smoking prevalence from the World Health Organization Global TB Report (2017), tobacco surveillance reports (2015), and the Tobacco Atlas. Risk ratios for the effect of smoking on TB incidence and TB mortality were obtained from published meta-analyses. An estimated 17.6% (95% confidence interval (CI): 8.4, 21.4) of TB cases and 15.2% (95% CI: 1.8, 31.9) of TB mortality were attributable to smoking. Among high-TB-burden countries, Russia had the highest proportion of smoking-attributable TB disease (31.6%, 95% CI: 15.9, 37.6) and deaths (28.1%, 95% CI: 3.8, 51.4). Men had a greater proportion of TB cases attributable to smoking (30.3%, 95% CI: 14.7, 36.6) than did women (4.3, 95% CI: 1.7, 5.7). Our findings highlight the need for tobacco control in high-TB-burden countries to combat TB incidence and TB mortality.

9 August 2018 in Current Diabetes Reports
Verified
Journal Article
Closed access
PDF file
MMMatthew J. Magee
Matthew J. Magee
ASArgita D. Salindri
Argita D. Salindri
NKNang Thu Thu Kyaw
Nang Thu Thu Kyaw
SASara C. Auld
Sara C. Auld
JHJ. Sonya Haw
J. Sonya Haw
GUGuillermo E. Umpierrez
Guillermo E. Umpierrez

1 July 2019 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
ASArgita D. Salindri
Argita D. Salindri
Jann-Yuan WangJann-Yuan Wang
Jann-Yuan Wang
HLHsien-Ho Lin
Hsien-Ho Lin
MMMatthew J. Magee
Matthew J. Magee
To estimate the incidence of diabetes, acute myocardial infarction (AMI), and stroke; and to determine factors associated with diabetes, AMI, and stroke incidence among patients previously treated for tuberculosis (TB) disease. A retrospective cohort study was conducted among non-pediatric TB patients registered in the Taiwan National Health Insurance Research Database (NHIRD) from 2002-2013. Diabetes, AMI, and stroke incidence were defined by International Classification of Diseases (ICD)-9 codes, drug prescriptions, and records of patient's clinic visits. Cox proportional hazard models were used to estimate the hazard rate ratio (HR) of incident diabetes, AMI, and stroke. From 2002-2013, there were 157,444 patients treated for TB registered in NHIRD. Among 129,453 patients with no prior history of diabetes, the age-adjusted incidence rate (IR) of diabetes was 3.85 (95%CI 3.70-4.01) per 1000 person-years. Among 143,646 patients with no prior history of AMI, the age-adjusted IR of AMI as 3.26 (95%CI 3.13-3.40). Among 118,774 patients with no prior history of stroke, the age-adjusted IR of stroke was 16.08 (95%CI 15.76-16.32). Chronic non-communicable disease risk factors like dyslipidemia, hypertension, and chronic kidney disease diagnosed before time of TB diagnosis were predictive of diabetes, AMI, and stroke incidence.

5 December 2018 in European Respiratory Journal
Verified
Journal Article
Closed access
PDF file
MMMatthew J. Magee
Matthew J. Magee
ASArgita D. Salindri
Argita D. Salindri
HKHardy Kornfeld
Hardy Kornfeld
ASAmit Singhal
Amit Singhal

1 May 2020 in Tuberculosis
Verified
Journal Article
Closed access
MMMatthew J. Magee
Matthew J. Magee
STSusanna L. Trost
Susanna L. Trost
ASArgita D. Salindri
Argita D. Salindri
GAGenet Amere
Genet Amere
CDCheryl L. Day
Cheryl L. Day
NGNeel R. Gandhi
Neel R. Gandhi

12 March 2024 in BMJ Open
Verified
Journal Article
Open access
PDF file
ASArgita D Salindri
Argita D Salindri
SASara C Auld
Sara C Auld
UGUnjali P Gujral
Unjali P Gujral
EUElaine M Urbina
Elaine M Urbina
JAJason R Andrews
Jason R Andrews
MMMatthew J Magee
Matthew J Magee
Objectives Tuberculosis infection (TBI) is marked by dynamic host–pathogen interactions with persistent low-grade inflammation and is associated with increased risk of cardiovascular diseases (CVD) including acute coronary syndrome, myocardial infarction and stroke. However, few studies assess the relationship between TBI and hypertension, an intermediate of CVD. We sought to determine the association between TBI and hypertension using data representative of the adult US population. Methods We performed cross-sectional analyses using data from the 2011–2012 US National Health and Nutrition Examination Survey (NHANES). Eligible participants included adults with valid QuantiFERON-TB Gold In-Tube (QFT-GIT) test results who also had blood pressure measures and no history of TB disease. TBI was defined by a positive QFT-GIT. We defined hypertension by either elevated measured blood pressure levels (ie, systolic ≥130 mm Hg or diastolic ≥80 mm Hg) or known hypertension indications (ie, self-reported previous diagnosis or use of antihypertensive medications). Analyses were performed using robust quasi-Poisson regressions and accounted for the stratified probability sampling design of NHANES. Results The overall prevalence of TBI was 5.7% (95% CI 4.7% to 6.7%) and hypertension was present among 48.9% (95% CI 45.2% to 52.7%) of participants. The prevalence of hypertension was higher among those with TBI (58.5%, 95% CI 52.4% to 64.5%) than those without TBI (48.3%, 95% CI 44.5% to 52.1%) (prevalence ratio (PR) 1.2, 95% CI 1.1 to 1.3). However, after adjusting for confounders, the prevalence of hypertension was similar for those with and without TBI (adjusted PR 1.0, 95% CI 1.0 to 1.1). The unadjusted prevalence of hypertension was higher among those with TBI versus no TBI, especially among individuals without CVD risk factors including those with normal body mass index (PR 1.6, 95% CI 1.2 to 2.0), euglycaemia (PR 1.3, 95% CI 1.1 to 1.5) or non-smokers (PR 1.2, 95% CI 1.1 to 1.4). Conclusions More than half of adults with TBI in the USA had hypertension. Importantly, we observed a relationship between TBI and hypertension among those without established CVD risk factors. Summary The prevalence of hypertension was high (59%) among adults with TBI in the USA. In addition, we found that the prevalence of hypertension was significantly higher among adults with positive QFT without established hypertension risk factors.